In the last 12 months, insiders at Crispr Therapeutics AG made open-market sales of $17.94 million (327.42K shares) and bought no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Samarth Kulkarni | Chief Executive Officer | 311,899 | 0 | 311,899 | 56.7% | 20 Oct, 2026 |
| 2 | James R. Kasinger | General Counsel And Secretary | 95,857 | 0 | 95,857 | 17.4% | 15 Oct, 2026 |
| 3 | Lawrence Otto Klein | Cbo Coo | 26,797 | 0 | 26,797 | 4.9% | 14 Mar, 2022 |
| 4 | Douglas A Treco | Director | 22,000 | 0 | 22,000 | 4.0% | 08 Aug, 2025 |
| 5 | Naimish Patel | Chief Medical Officer | 19,357 | 0 | 19,357 | 3.5% | 01 Jun, 2026 |
| 6 | Ali Behbahani | Director | 16,637 | 0 | 16,637 | 3.0% | 21 Sep, 2026 |
| 7 | Simeon George | Director | 15,486 | 0 | 15,486 | 2.8% | 16 Oct, 2026 |
| 8 | Raju Prasad | Chief Financial Officer | 14,815 | 0 | 14,815 | 2.7% | 11 Aug, 2026 |
| 9 | Julianne Bruno | Chief Operating Officer | 10,544 | 0 | 10,544 | 1.9% | 24 Mar, 2025 |
| 10 | John Greene | Director | 7,000 | 0 | 7,000 | 1.3% | 28 Feb, 2025 |
| 11 | Brendan Smith | Chief Financial Officer | 5,072 | 0 | 5,072 | 0.9% | 22 Feb, 2023 |
| 12 | Phuong Khanh Morrow | Chief Medical Officer | 4,411 | 0 | 4,411 | 0.8% | 25 May, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Nov, 2026 | Sivakesava Sakhamuri | Chief Technical Officer | Acquired A | 90,000 | $0.00 | $0 | 90,000 | Direct |
| 04 Nov, 2026 | Sivakesava Sakhamuri | Chief Technical Officer | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 26 Oct, 2026 | James R. Kasinger | General Counsel And Secretary | Acquired A | 18,000 | $0.00 | $0 | 18,000 | Direct |
| 26 Oct, 2026 | Naimish Patel | Chief Medical Officer | Acquired A | 24,000 | $0.00 | $0 | 24,000 | Direct |
| 26 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Acquired A | 57,500 | $0.00 | $0 | 57,500 | Direct |
| 26 Oct, 2026 | Andrew Jacob Silver | Chief Financial Officer | Acquired A | 18,000 | $0.00 | $0 | 18,000 | Direct |
| 26 Oct, 2026 | Andrew Jacob Silver | Chief Financial Officer | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 26 Oct, 2026 | James R. Kasinger | General Counsel And Secretary | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 26 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Acquired A | 28,750 | $0.00 | $0 | 28,750 | Direct |
| 26 Oct, 2026 | Naimish Patel | Chief Medical Officer | Acquired A | 12,000 | $0.00 | $0 | 12,000 | Direct |
| 19 Oct, 2026 | Andrew Jacob Silver | Chief Financial Officer | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 16 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Acquired M | 100,000 | — | — | 359,736 | Direct |
| 19 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Disposed S | 47,837 | $49.78 | $2.38Mn | 311,899 | Direct |
| 16 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Disposed M | 100,000 | — | — | 200,000 | Direct |
| 14 Oct, 2026 | Simeon George | Director | Acquired M | 30,000 | $14.00 | $420.00K | 30,000 | Direct |
| 14 Oct, 2026 | Simeon George | Director | Disposed S | 14,514 | $49.63 | $720.37K | 15,486 | Direct |
| 14 Oct, 2026 | Simeon George | Director | Disposed M | 30,000 | $0.00 | $0 | 0 | Direct |
| 13 Oct, 2026 | Samarth Kulkarni | Chief Executive Officer | Acquired M | 8,333 | — | — | 263,834 | Direct |
| 13 Oct, 2026 | James R. Kasinger | General Counsel And Secretary | Acquired M | 2,113 | — | — | 96,897 | Direct |
| 14 Oct, 2026 | James R. Kasinger | General Counsel And Secretary | Disposed S | 1,040 | $49.26 | $51.23K | 95,857 | Direct |